ABSTRACT
We describe a case of acute intermittent porphyria in a woman who presented repeatedly with abdominal pain. Porphyrias are caused by decreased enzyme activity in the heme biosynthetic pathway leading to overproduction of heme precursors if demand increases. This can cause symptoms such as abdominal pain, nausea and vomiting, constipation, tachycardia and hypertension. Treatment includes removal of causative factors, administration of carbohydrates or hemin to reduce the production of heme precursors as well as symptomatic treatment.
Subject(s)
Abdominal Pain/etiology , Porphyria, Acute Intermittent/complications , Abdominal Pain/metabolism , Abdominal Pain/therapy , Carbohydrates/therapeutic use , Female , Heme/biosynthesis , Hemin/therapeutic use , Humans , Porphyria, Acute Intermittent/metabolism , Porphyria, Acute Intermittent/therapyABSTRACT
BACKGROUND: Nocardia is a rare pathogen of mainly immunocomprised patients. Only two cases of nocardiosis have previously been identified in Iceland. CASE DESCRIPTION: A 92-year-old male on glucocorticoid therapy with metastatic bladder cancer presented with two weeks history of progressive swelling and erythema of the hand and deteriorating cognitive functioning. A brain lesion and pulmonary nodules were identified and Nocardia farcinia was cultured from a hand abscess. The patient was initially treated with trimethoprim/sulfamethoxazole but because of rapid deterioration and old age an end-of-life decision was made. CONCLUSION: This case of nocardiosis illustrates the importance of uncommon opportunistic infections in immunocompromised Icelandic patients.
Subject(s)
Cellulitis/microbiology , Glucocorticoids/adverse effects , Immunocompromised Host , Nocardia Infections/microbiology , Opportunistic Infections/microbiology , Urinary Bladder Neoplasms/drug therapy , Aged, 80 and over , Anti-Infective Agents/therapeutic use , Cellulitis/drug therapy , Cellulitis/immunology , Cellulitis/pathology , Edema/microbiology , Erythema/microbiology , Hand , Humans , Male , Nocardia/isolation & purification , Nocardia Infections/drug therapy , Nocardia Infections/immunology , Nocardia Infections/pathology , Opportunistic Infections/drug therapy , Opportunistic Infections/immunology , Opportunistic Infections/pathology , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use , Urinary Bladder Neoplasms/immunology , Urinary Bladder Neoplasms/secondaryABSTRACT
A 49 year old previously healthy smoker was diagnosed with a giant bulla in his right lung, following a history of dry cough, repeated upper airway infections and increasing dyspnea for several years. Computed tomography (CT) confirmed the presence of a giant bulla in the right inferior lobe and several smaller bullae in the right superior lobe. The giant bulla was 17 cm in diameter, occupying more than half of the right hemithorax. On spirometry a moderate restrictive and a mild obstructive pattern was observed. Lung volume was measured with two different techniques, nitrogen washout and plethysmography, with volume of the bullae estimated at 2.9 L, similar to the 3.2 L determined by CT. The patient underwent thoracotomy, where the giant bulla together with the inferior lobe were removed with lobectomy and the small bullae in the superior lobe with wedge resection. Five months postoperatively the patient is in good health and is back at work. Postoperatively significant improvements in spirometry values and lung volume measurements have been documented. This case demonstrates that giant bullae can be successfully managed with surgical resection and their size can be determined by different techniques, including lung volume measurements and chest CT.